0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Formulation Development Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-8O11587
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Formulation Development Market Research Report 2022
BUY CHAPTERS

Global Pharmaceutical Formulation Development Market Research Report 2024

Code: QYRE-Auto-8O11587
Report
June 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Formulation Development Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceutical Formulation Development Market

Pharmaceutical Formulation Development Market

Pharmaceutical formulation development is the process of designing and developing a dosage form or drug product that contains the active pharmaceutical ingredient (API) in a suitable form for administration to patients. It involves the selection of appropriate excipients, development of a stable and effective formulation, and optimization of the manufacturing process.
The goal of formulation development is to ensure that the drug product is safe, effective, and of high quality. It involves various stages, including pre-formulation studies, formulation design, process development, and optimization. The formulation development team works closely with other departments, such as analytical development, regulatory affairs, and manufacturing, to ensure that the final product meets all the necessary requirements.
During the formulation development process, factors such as the physicochemical properties of the API, desired route of administration, patient population, and stability considerations are taken into account. Different dosage forms, such as tablets, capsules, liquids, creams, and injectables, may be developed depending on the specific requirements of the drug.
Formulation development also involves conducting stability studies to assess the shelf-life of the drug product under various storage conditions. This helps to ensure that the formulation remains stable and retains its potency and quality throughout its intended shelf-life.
The global Pharmaceutical Formulation Development market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Formulation Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Formulation Development.

Report Scope

The Pharmaceutical Formulation Development market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Formulation Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Formulation Development companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Formulation Development Market Report

Report Metric Details
Report Name Pharmaceutical Formulation Development Market
CAGR 5%
Segment by Type
  • Oral
  • External Use
Segment by Application
  • Hospital
  • Enterprise
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company LGM Pharma, Dalton Pharma Services, Recipharm, Aurigene Pharmaceutical Services, Coriolis Pharma, Intertek, Quay Pharma, Lonza, Ardena, Kemwell, SGS, Syngene International, Piramal Pharma Solutions, Pharma Mo Ltd, Metrics Contract Services, COREALIS Pharma, Element Materials Technology, Adare Pharma Solutions, Singota Solutions, Creative Biolabs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical Formulation Development companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical Formulation Development Market report?

Ans: The main players in the Pharmaceutical Formulation Development Market are LGM Pharma, Dalton Pharma Services, Recipharm, Aurigene Pharmaceutical Services, Coriolis Pharma, Intertek, Quay Pharma, Lonza, Ardena, Kemwell, SGS, Syngene International, Piramal Pharma Solutions, Pharma Mo Ltd, Metrics Contract Services, COREALIS Pharma, Element Materials Technology, Adare Pharma Solutions, Singota Solutions, Creative Biolabs

What are the Application segmentation covered in the Pharmaceutical Formulation Development Market report?

Ans: The Applications covered in the Pharmaceutical Formulation Development Market report are Hospital, Enterprise

What are the Type segmentation covered in the Pharmaceutical Formulation Development Market report?

Ans: The Types covered in the Pharmaceutical Formulation Development Market report are Oral, External Use

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Formulation Development Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 External Use
1.3 Market by Application
1.3.1 Global Pharmaceutical Formulation Development Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Enterprise
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Formulation Development Market Perspective (2019-2030)
2.2 Pharmaceutical Formulation Development Growth Trends by Region
2.2.1 Global Pharmaceutical Formulation Development Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Formulation Development Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Formulation Development Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Formulation Development Market Dynamics
2.3.1 Pharmaceutical Formulation Development Industry Trends
2.3.2 Pharmaceutical Formulation Development Market Drivers
2.3.3 Pharmaceutical Formulation Development Market Challenges
2.3.4 Pharmaceutical Formulation Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Formulation Development Players by Revenue
3.1.1 Global Top Pharmaceutical Formulation Development Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Formulation Development Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Formulation Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Formulation Development Revenue
3.4 Global Pharmaceutical Formulation Development Market Concentration Ratio
3.4.1 Global Pharmaceutical Formulation Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Formulation Development Revenue in 2023
3.5 Pharmaceutical Formulation Development Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Formulation Development Product Solution and Service
3.7 Date of Enter into Pharmaceutical Formulation Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Formulation Development Breakdown Data by Type
4.1 Global Pharmaceutical Formulation Development Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Formulation Development Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Formulation Development Breakdown Data by Application
5.1 Global Pharmaceutical Formulation Development Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Formulation Development Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Formulation Development Market Size (2019-2030)
6.2 North America Pharmaceutical Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Formulation Development Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Formulation Development Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Formulation Development Market Size (2019-2030)
7.2 Europe Pharmaceutical Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Formulation Development Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Formulation Development Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Formulation Development Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Formulation Development Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Formulation Development Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Formulation Development Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Formulation Development Market Size (2019-2030)
9.2 Latin America Pharmaceutical Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Formulation Development Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Formulation Development Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Formulation Development Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LGM Pharma
11.1.1 LGM Pharma Company Detail
11.1.2 LGM Pharma Business Overview
11.1.3 LGM Pharma Pharmaceutical Formulation Development Introduction
11.1.4 LGM Pharma Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.1.5 LGM Pharma Recent Development
11.2 Dalton Pharma Services
11.2.1 Dalton Pharma Services Company Detail
11.2.2 Dalton Pharma Services Business Overview
11.2.3 Dalton Pharma Services Pharmaceutical Formulation Development Introduction
11.2.4 Dalton Pharma Services Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.2.5 Dalton Pharma Services Recent Development
11.3 Recipharm
11.3.1 Recipharm Company Detail
11.3.2 Recipharm Business Overview
11.3.3 Recipharm Pharmaceutical Formulation Development Introduction
11.3.4 Recipharm Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.3.5 Recipharm Recent Development
11.4 Aurigene Pharmaceutical Services
11.4.1 Aurigene Pharmaceutical Services Company Detail
11.4.2 Aurigene Pharmaceutical Services Business Overview
11.4.3 Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Introduction
11.4.4 Aurigene Pharmaceutical Services Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.4.5 Aurigene Pharmaceutical Services Recent Development
11.5 Coriolis Pharma
11.5.1 Coriolis Pharma Company Detail
11.5.2 Coriolis Pharma Business Overview
11.5.3 Coriolis Pharma Pharmaceutical Formulation Development Introduction
11.5.4 Coriolis Pharma Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.5.5 Coriolis Pharma Recent Development
11.6 Intertek
11.6.1 Intertek Company Detail
11.6.2 Intertek Business Overview
11.6.3 Intertek Pharmaceutical Formulation Development Introduction
11.6.4 Intertek Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.6.5 Intertek Recent Development
11.7 Quay Pharma
11.7.1 Quay Pharma Company Detail
11.7.2 Quay Pharma Business Overview
11.7.3 Quay Pharma Pharmaceutical Formulation Development Introduction
11.7.4 Quay Pharma Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.7.5 Quay Pharma Recent Development
11.8 Lonza
11.8.1 Lonza Company Detail
11.8.2 Lonza Business Overview
11.8.3 Lonza Pharmaceutical Formulation Development Introduction
11.8.4 Lonza Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.8.5 Lonza Recent Development
11.9 Ardena
11.9.1 Ardena Company Detail
11.9.2 Ardena Business Overview
11.9.3 Ardena Pharmaceutical Formulation Development Introduction
11.9.4 Ardena Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.9.5 Ardena Recent Development
11.10 Kemwell
11.10.1 Kemwell Company Detail
11.10.2 Kemwell Business Overview
11.10.3 Kemwell Pharmaceutical Formulation Development Introduction
11.10.4 Kemwell Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.10.5 Kemwell Recent Development
11.11 SGS
11.11.1 SGS Company Detail
11.11.2 SGS Business Overview
11.11.3 SGS Pharmaceutical Formulation Development Introduction
11.11.4 SGS Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.11.5 SGS Recent Development
11.12 Syngene International
11.12.1 Syngene International Company Detail
11.12.2 Syngene International Business Overview
11.12.3 Syngene International Pharmaceutical Formulation Development Introduction
11.12.4 Syngene International Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.12.5 Syngene International Recent Development
11.13 Piramal Pharma Solutions
11.13.1 Piramal Pharma Solutions Company Detail
11.13.2 Piramal Pharma Solutions Business Overview
11.13.3 Piramal Pharma Solutions Pharmaceutical Formulation Development Introduction
11.13.4 Piramal Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.13.5 Piramal Pharma Solutions Recent Development
11.14 Pharma Mo Ltd
11.14.1 Pharma Mo Ltd Company Detail
11.14.2 Pharma Mo Ltd Business Overview
11.14.3 Pharma Mo Ltd Pharmaceutical Formulation Development Introduction
11.14.4 Pharma Mo Ltd Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.14.5 Pharma Mo Ltd Recent Development
11.15 Metrics Contract Services
11.15.1 Metrics Contract Services Company Detail
11.15.2 Metrics Contract Services Business Overview
11.15.3 Metrics Contract Services Pharmaceutical Formulation Development Introduction
11.15.4 Metrics Contract Services Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.15.5 Metrics Contract Services Recent Development
11.16 COREALIS Pharma
11.16.1 COREALIS Pharma Company Detail
11.16.2 COREALIS Pharma Business Overview
11.16.3 COREALIS Pharma Pharmaceutical Formulation Development Introduction
11.16.4 COREALIS Pharma Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.16.5 COREALIS Pharma Recent Development
11.17 Element Materials Technology
11.17.1 Element Materials Technology Company Detail
11.17.2 Element Materials Technology Business Overview
11.17.3 Element Materials Technology Pharmaceutical Formulation Development Introduction
11.17.4 Element Materials Technology Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.17.5 Element Materials Technology Recent Development
11.18 Adare Pharma Solutions
11.18.1 Adare Pharma Solutions Company Detail
11.18.2 Adare Pharma Solutions Business Overview
11.18.3 Adare Pharma Solutions Pharmaceutical Formulation Development Introduction
11.18.4 Adare Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.18.5 Adare Pharma Solutions Recent Development
11.19 Singota Solutions
11.19.1 Singota Solutions Company Detail
11.19.2 Singota Solutions Business Overview
11.19.3 Singota Solutions Pharmaceutical Formulation Development Introduction
11.19.4 Singota Solutions Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.19.5 Singota Solutions Recent Development
11.20 Creative Biolabs
11.20.1 Creative Biolabs Company Detail
11.20.2 Creative Biolabs Business Overview
11.20.3 Creative Biolabs Pharmaceutical Formulation Development Introduction
11.20.4 Creative Biolabs Revenue in Pharmaceutical Formulation Development Business (2019-2024)
11.20.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Pharmaceutical Formulation Development Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of External Use
    Table 4. Global Pharmaceutical Formulation Development Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Pharmaceutical Formulation Development Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Pharmaceutical Formulation Development Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Pharmaceutical Formulation Development Market Share by Region (2019-2024)
    Table 8. Global Pharmaceutical Formulation Development Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Pharmaceutical Formulation Development Market Share by Region (2025-2030)
    Table 10. Pharmaceutical Formulation Development Market Trends
    Table 11. Pharmaceutical Formulation Development Market Drivers
    Table 12. Pharmaceutical Formulation Development Market Challenges
    Table 13. Pharmaceutical Formulation Development Market Restraints
    Table 14. Global Pharmaceutical Formulation Development Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Pharmaceutical Formulation Development Market Share by Players (2019-2024)
    Table 16. Global Top Pharmaceutical Formulation Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Formulation Development as of 2023)
    Table 17. Ranking of Global Top Pharmaceutical Formulation Development Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Pharmaceutical Formulation Development Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Pharmaceutical Formulation Development Product Solution and Service
    Table 21. Date of Enter into Pharmaceutical Formulation Development Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Pharmaceutical Formulation Development Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Pharmaceutical Formulation Development Revenue Market Share by Type (2019-2024)
    Table 25. Global Pharmaceutical Formulation Development Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Pharmaceutical Formulation Development Revenue Market Share by Type (2025-2030)
    Table 27. Global Pharmaceutical Formulation Development Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Pharmaceutical Formulation Development Revenue Market Share by Application (2019-2024)
    Table 29. Global Pharmaceutical Formulation Development Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Pharmaceutical Formulation Development Revenue Market Share by Application (2025-2030)
    Table 31. North America Pharmaceutical Formulation Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Pharmaceutical Formulation Development Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Pharmaceutical Formulation Development Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Pharmaceutical Formulation Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Pharmaceutical Formulation Development Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Pharmaceutical Formulation Development Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Pharmaceutical Formulation Development Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Pharmaceutical Formulation Development Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Pharmaceutical Formulation Development Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Pharmaceutical Formulation Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Pharmaceutical Formulation Development Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Pharmaceutical Formulation Development Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Pharmaceutical Formulation Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2025-2030) & (US$ Million)
    Table 46. LGM Pharma Company Detail
    Table 47. LGM Pharma Business Overview
    Table 48. LGM Pharma Pharmaceutical Formulation Development Product
    Table 49. LGM Pharma Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 50. LGM Pharma Recent Development
    Table 51. Dalton Pharma Services Company Detail
    Table 52. Dalton Pharma Services Business Overview
    Table 53. Dalton Pharma Services Pharmaceutical Formulation Development Product
    Table 54. Dalton Pharma Services Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 55. Dalton Pharma Services Recent Development
    Table 56. Recipharm Company Detail
    Table 57. Recipharm Business Overview
    Table 58. Recipharm Pharmaceutical Formulation Development Product
    Table 59. Recipharm Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 60. Recipharm Recent Development
    Table 61. Aurigene Pharmaceutical Services Company Detail
    Table 62. Aurigene Pharmaceutical Services Business Overview
    Table 63. Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Product
    Table 64. Aurigene Pharmaceutical Services Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 65. Aurigene Pharmaceutical Services Recent Development
    Table 66. Coriolis Pharma Company Detail
    Table 67. Coriolis Pharma Business Overview
    Table 68. Coriolis Pharma Pharmaceutical Formulation Development Product
    Table 69. Coriolis Pharma Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 70. Coriolis Pharma Recent Development
    Table 71. Intertek Company Detail
    Table 72. Intertek Business Overview
    Table 73. Intertek Pharmaceutical Formulation Development Product
    Table 74. Intertek Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 75. Intertek Recent Development
    Table 76. Quay Pharma Company Detail
    Table 77. Quay Pharma Business Overview
    Table 78. Quay Pharma Pharmaceutical Formulation Development Product
    Table 79. Quay Pharma Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 80. Quay Pharma Recent Development
    Table 81. Lonza Company Detail
    Table 82. Lonza Business Overview
    Table 83. Lonza Pharmaceutical Formulation Development Product
    Table 84. Lonza Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 85. Lonza Recent Development
    Table 86. Ardena Company Detail
    Table 87. Ardena Business Overview
    Table 88. Ardena Pharmaceutical Formulation Development Product
    Table 89. Ardena Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 90. Ardena Recent Development
    Table 91. Kemwell Company Detail
    Table 92. Kemwell Business Overview
    Table 93. Kemwell Pharmaceutical Formulation Development Product
    Table 94. Kemwell Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 95. Kemwell Recent Development
    Table 96. SGS Company Detail
    Table 97. SGS Business Overview
    Table 98. SGS Pharmaceutical Formulation Development Product
    Table 99. SGS Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 100. SGS Recent Development
    Table 101. Syngene International Company Detail
    Table 102. Syngene International Business Overview
    Table 103. Syngene International Pharmaceutical Formulation Development Product
    Table 104. Syngene International Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 105. Syngene International Recent Development
    Table 106. Piramal Pharma Solutions Company Detail
    Table 107. Piramal Pharma Solutions Business Overview
    Table 108. Piramal Pharma Solutions Pharmaceutical Formulation Development Product
    Table 109. Piramal Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 110. Piramal Pharma Solutions Recent Development
    Table 111. Pharma Mo Ltd Company Detail
    Table 112. Pharma Mo Ltd Business Overview
    Table 113. Pharma Mo Ltd Pharmaceutical Formulation Development Product
    Table 114. Pharma Mo Ltd Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 115. Pharma Mo Ltd Recent Development
    Table 116. Metrics Contract Services Company Detail
    Table 117. Metrics Contract Services Business Overview
    Table 118. Metrics Contract Services Pharmaceutical Formulation Development Product
    Table 119. Metrics Contract Services Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 120. Metrics Contract Services Recent Development
    Table 121. COREALIS Pharma Company Detail
    Table 122. COREALIS Pharma Business Overview
    Table 123. COREALIS Pharma Pharmaceutical Formulation Development Product
    Table 124. COREALIS Pharma Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 125. COREALIS Pharma Recent Development
    Table 126. Element Materials Technology Company Detail
    Table 127. Element Materials Technology Business Overview
    Table 128. Element Materials Technology Pharmaceutical Formulation Development Product
    Table 129. Element Materials Technology Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 130. Element Materials Technology Recent Development
    Table 131. Adare Pharma Solutions Company Detail
    Table 132. Adare Pharma Solutions Business Overview
    Table 133. Adare Pharma Solutions Pharmaceutical Formulation Development Product
    Table 134. Adare Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 135. Adare Pharma Solutions Recent Development
    Table 136. Singota Solutions Company Detail
    Table 137. Singota Solutions Business Overview
    Table 138. Singota Solutions Pharmaceutical Formulation Development Product
    Table 139. Singota Solutions Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 140. Singota Solutions Recent Development
    Table 141. Creative Biolabs Company Detail
    Table 142. Creative Biolabs Business Overview
    Table 143. Creative Biolabs Pharmaceutical Formulation Development Product
    Table 144. Creative Biolabs Revenue in Pharmaceutical Formulation Development Business (2019-2024) & (US$ Million)
    Table 145. Creative Biolabs Recent Development
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmaceutical Formulation Development Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Pharmaceutical Formulation Development Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. External Use Features
    Figure 5. Global Pharmaceutical Formulation Development Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Pharmaceutical Formulation Development Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Enterprise Case Studies
    Figure 9. Pharmaceutical Formulation Development Report Years Considered
    Figure 10. Global Pharmaceutical Formulation Development Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Pharmaceutical Formulation Development Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Pharmaceutical Formulation Development Market Share by Region: 2023 VS 2030
    Figure 13. Global Pharmaceutical Formulation Development Market Share by Players in 2023
    Figure 14. Global Top Pharmaceutical Formulation Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Formulation Development as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Pharmaceutical Formulation Development Revenue in 2023
    Figure 16. North America Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Pharmaceutical Formulation Development Market Share by Country (2019-2030)
    Figure 18. United States Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. Canada Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Europe Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Pharmaceutical Formulation Development Market Share by Country (2019-2030)
    Figure 22. Germany Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. France Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. U.K. Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Italy Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Russia Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Nordic Countries Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Asia-Pacific Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Pharmaceutical Formulation Development Market Share by Region (2019-2030)
    Figure 30. China Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Japan Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. South Korea Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Southeast Asia Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. India Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Australia Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Latin America Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Pharmaceutical Formulation Development Market Share by Country (2019-2030)
    Figure 38. Mexico Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Brazil Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Pharmaceutical Formulation Development Market Share by Country (2019-2030)
    Figure 42. Turkey Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Saudi Arabia Pharmaceutical Formulation Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. LGM Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 45. Dalton Pharma Services Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 46. Recipharm Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 47. Aurigene Pharmaceutical Services Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 48. Coriolis Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 49. Intertek Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 50. Quay Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 51. Lonza Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 52. Ardena Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 53. Kemwell Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 54. SGS Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 55. Syngene International Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 56. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 57. Pharma Mo Ltd Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 58. Metrics Contract Services Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 59. COREALIS Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 60. Element Materials Technology Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 61. Adare Pharma Solutions Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 62. Singota Solutions Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 63. Creative Biolabs Revenue Growth Rate in Pharmaceutical Formulation Development Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cell Culturing Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39H7900
Sat Jul 20 00:00:00 UTC 2024

Add to Cart

Global Medical Photobiostimulation System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-12C8121
Sat Jul 20 00:00:00 UTC 2024

Add to Cart

Global Aseptic Processing Technology Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8K3254
Sat Jul 20 00:00:00 UTC 2024

Add to Cart

Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23P5573
Sat Jul 20 00:00:00 UTC 2024

Add to Cart